Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1981 1
1983 1
1989 1
1990 4
1991 1
1993 2
1994 2
1995 6
1996 8
1997 2
1998 2
2000 2
2001 1
2002 2
2006 1
2007 1
2008 2
2009 3
2011 4
2012 9
2013 5
2014 7
2015 10
2016 7
2017 6
2018 2
2019 7
2020 13
2021 11
2022 13
2023 16
2024 10
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Tabernero J, Yoshino T, Cohn AL, Obermannova R, Bodoky G, Garcia-Carbonero R, Ciuleanu TE, Portnoy DC, Van Cutsem E, Grothey A, Prausová J, Garcia-Alfonso P, Yamazaki K, Clingan PR, Lonardi S, Kim TW, Simms L, Chang SC, Nasroulah F; RAISE Study Investigators. Tabernero J, et al. Lancet Oncol. 2015 May;16(5):499-508. doi: 10.1016/S1470-2045(15)70127-0. Epub 2015 Apr 12. Lancet Oncol. 2015. PMID: 25877855 Clinical Trial.
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.
Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T, Streiff MB, Garcia DA, Liebman HA, Belani CP, O'Reilly EM, Patel JN, Yimer HA, Wildgoose P, Burton P, Vijapurkar U, Kaul S, Eikelboom J, McBane R, Bauer KA, Kuderer NM, Lyman GH; CASSINI Investigators. Khorana AA, et al. N Engl J Med. 2019 Feb 21;380(8):720-728. doi: 10.1056/NEJMoa1814630. N Engl J Med. 2019. PMID: 30786186 Clinical Trial.
Addressing Sustainability in the Operating Room.
Melnyk AI, Niino C, Wright KN. Melnyk AI, et al. Urogynecology (Phila). 2023 Sep 1;29(9):719-724. doi: 10.1097/SPV.0000000000001395. Epub 2023 Jul 13. Urogynecology (Phila). 2023. PMID: 37493260 No abstract available.
No-Show Rates in a Urogynecology Clinic.
Melnyk AI, Pollard A, Matten N, Napoe GS. Melnyk AI, et al. Urogynecology (Phila). 2024 Mar 1;30(3):314-319. doi: 10.1097/SPV.0000000000001475. Urogynecology (Phila). 2024. PMID: 38484248 Free PMC article.
Sustainability in Obstetrics and Gynecology.
Wright KN, Melnyk AI, Emont J, Van Dis J. Wright KN, et al. Among authors: melnyk ai. Obstet Gynecol. 2023 Dec 1;142(6):1341-1346. doi: 10.1097/AOG.0000000000005435. Epub 2023 Nov 8. Obstet Gynecol. 2023. PMID: 37944151 Review.
Going green in gynecology: a call to action.
Melnyk AI, Woods N, Moalli P. Melnyk AI, et al. Am J Obstet Gynecol. 2023 Sep;229(3):269-274. doi: 10.1016/j.ajog.2023.04.025. Epub 2023 Apr 26. Am J Obstet Gynecol. 2023. PMID: 37116823
Materialism.
Melnyk A. Melnyk A. Wiley Interdiscip Rev Cogn Sci. 2012 May;3(3):281-292. doi: 10.1002/wcs.1174. Epub 2012 Mar 14. Wiley Interdiscip Rev Cogn Sci. 2012. PMID: 26301463
154 results